A Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Docosahexaenoic Acid (DHA) in Slowing the Progression of Alzheimer's Disease

The PI of this project was: Sanjay Asthana, MD

This project was funded by: Alzheimer's Disease Cooperative Study (ADCS)

The term of this project was: February 2007 to June 2010

The number of subjects scanned during this project was: 20